Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week

The,Doctor,Shows,The,Scales,Of,Justice,On,The,Tablet.

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are building on recent gains, trading higher as investor focus intensifies on a key, upcoming catalyst. Here’s what investors need to know.

What To Know: The stock surged Tuesday following the release of the company’s second-quarter financial results, which painted a picture of forward-looking optimism despite mixed top-line numbers. Tonix posted a second-quarter net loss of $3.86 per share, beating the analyst consensus estimate of a $10.73 loss per share.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.